Ionis Pharmaceuticals, Inc.IONSNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-51.96
↑ 73% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-195.14
Historical baseline
PeriodValueYoY Change
2025-51.96-187.1%
2024-18.10+48.5%
2023-35.14-24.1%
2022-28.32+96.9%
2021-900.76-1091.6%
2020-75.59-424.8%
201923.27+105.8%
2018-398.97-316.3%
2017184.46+128.4%
2016-650.26-